Earlier this month we posited the idea that 2021 could be the year of quantum computing-led drug discovery and predicted that partnerships like those of Google and European pharma giant Boehringer Ingelheim would be more common with more quantum hardware makers tying the knot with drug manufacturers. …
While this new year might not mark the moment when the first drugs are discovered via molecular dynamics simulations running on a full-scale quantum, there are several signs that a number of important collaborations between the few quantum vendors and major biotech companies are announced. …
For years, scientists in the field of molecular dynamics have been squeezed in their research. …
In Nvidia’s decade and a half push to make GPU acceleration core to all kinds of high performance computing, a key component has been the CUDA parallel computing platform that made it easier for developers to create applications that can leverage graphics chips for general purpose processing. …
Quantum simulators are a strange breed of systems for purposes that might seem a bit nebulous from the outset. …
Like all major server-focused tech companies, HPE has been keeping close tabs on where quantum computing might go in the future. …
The relationship between quantum computers and supercomputing will be more complementary than competitive in the coming years with quantum processors being the offload engines for some key workloads in materials science and other areas. …
Quantum systems will not replace traditional supercomputers anytime soon but for certain types of simulations, they will be far more efficient and scalable than classical machines, at least according to CEO of quantum computer maker D-Wave, Vern Brownell. …
Chocolate and peanut butter, tea and scones, gin and tonic, they’re all great combinations, and today we now have a new binary mixture — Quantum and AI. …
All Content Copyright The Next Platform